ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,068.50
0.03%
US Tech 100
21,119.60
0.00%
다우존스 지수
44,593.65
0.28%
Bitcoin
96,320.21
0.60%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) 뉴스

MEIP

MEI Pharma (MEIP)

MEI Pharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MEIP
일자시간출처헤드라인심볼기업
2025/02/0106:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/12/2107:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MEIPMEI Pharma Inc
2024/12/2107:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MEIPMEI Pharma Inc
2024/12/2107:10Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MEIPMEI Pharma Inc
2024/11/2606:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/11/1506:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/11/1306:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
2024/11/1306:05Business WireMEI Pharma Reports First Quarter Fiscal Year 2025 Cash PositionNASDAQ:MEIPMEI Pharma Inc
2024/10/2605:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/09/2006:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MEIPMEI Pharma Inc
2024/09/2006:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/09/2005:01Business WireMEI Pharma Reports Fiscal Year End 2024 Cash PositionNASDAQ:MEIPMEI Pharma Inc
2024/08/1221:30Business WireMEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic AlternativesNASDAQ:MEIPMEI Pharma Inc
2024/08/0305:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/07/3105:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/07/2306:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/07/2305:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MEIPMEI Pharma Inc
2024/07/2221:30Business WireMEI Pharma to Consider Strategic AlternativesNASDAQ:MEIPMEI Pharma Inc
2024/05/2205:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
2024/05/2202:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/05/2105:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
2024/05/1005:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
2024/05/1005:02Business WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
2024/05/1005:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
2024/04/1121:02Business WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
2024/04/1121:00Business WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
2024/04/1021:00Business WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
2024/03/2621:00Business WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
2024/02/2914:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
2024/02/2206:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
 검색 관련기사 보기:NASDAQ:MEIP

최근 히스토리

CCOM
US100
US Tech 100
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
ADAUSD
Cardano
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
USOTC
ADDYY
Adidas (QX)
AMEX
XLV
Health Care Select Sector
CCOM
SILVER
SILVER
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지